MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldactone 100mg tablets (Pfizer Ltd).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldactone 100mg tablets (Pfizer Ltd).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldactone 100mg tablets (Pfizer Ltd).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldactone 100mg tablets (Pfizer Ltd).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldactone 50mg tablets (Pfizer Ltd).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldactone 50mg tablets (Pfizer Ltd).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldactone 50mg tablets (Pfizer Ltd).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldactone 50mg tablets (Pfizer Ltd).

Stability Notes

Store in airtight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Amias 4mg tablets (Neon Healthcare Ltd).

Stability Notes

Store in airtight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Amias 8mg tablets (Neon Healthcare Ltd).

Stability Notes

Store in airtight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Amias 16mg tablets (Neon Healthcare Ltd).

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Celectol 200mg tablets (Neon Healthcare Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.